review of literature on clinical pancreatology - The Pancreapedia

405. Tonack S, Aspinall-O'Dea M, Neoptolemos JP, Costello E. Pancreatic cancer: proteomicapproaches to a challenging disease. Pancreatology 2009; 9: 567-76.406. Cui Y, Wu J, Zong M, Song G, Jia Q, Jiang J, Han J. Proteomic pr<strong>of</strong>iling in pancreatic cancer withand without lymph node metastasis. Int J Cancer 2009; 124: 1614-21.407. Shi C, Hruban RH, Klein AP. Familial pancreatic cancer. Arch Pathol Lab Med 2009; 133: 365-74.408. Klein AP, Borges M, Griffith M, Brune K, Hong SM, Omura N, Hruban RH, Goggins M. Absence<strong>of</strong> deleterious palladin mutations in patients with familial pancreatic cancer. Cancer EpidemiolBiomarkers Prev 2009; 18: 1328-30.409. Shi C, Hong SM, Lim P, Kamiyama H, Khan M, Anders RA, Goggins M, Hruban RH, EshlemanJR. KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those withPanIN: implications for the human pancreatic cancer cell <strong>of</strong> origin. Mol Cancer Res 2009; 7: 230-6.410. Snyder CS, Kaushal S, Kono Y, Cao HS, H<strong>of</strong>fman RM, Bouvet M. Complementarity <strong>of</strong> ultrasoundand fluorescence imaging in an orthotopic mouse model <strong>of</strong> pancreatic cancer. BMC Cancer 2009; 9:106.411. Levy MJ, Gleeson FC, Zhang L. Endoscopic ultrasound fine-needle aspiration detection <strong>of</strong>extravascular migratory metastasis from a remotely located pancreatic cancer. Clin GastroenterolHepatol 2009; 7: 246-8.412. Shibata K, Iwaki K, Kai S, Ohta M, Kitano S. Increased levels <strong>of</strong> both carbohydrate antigen 19-9and Duke pancreatic monoclonal antigen type 2 reflect postoperative prognosis in patients withpancreatic carcinoma. Pancreas 2009; 38: 619-24.413. Mayo SC, Austin DF, Sheppard BC, Mori M, Shipley DK, Billingsley KG. Evolving preoperativeevaluation <strong>of</strong> patients with pancreatic cancer: does laparoscopy have a role in the current era? J AmColl Surg 2009; 208: 87-95.414. Yamada S, Nakao A, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, Kodera Y, Takeda S.Pancreatic cancer with paraaortic lymph node metastasis: a contraindication for radical surgery?Pancreas 2009; 38: e13-7.415. Klimstra DS, Pitman MB, Hruban RH. An algorithmic approach to the diagnosis <strong>of</strong> pancreaticneoplasms. Arch Pathol Lab Med 2009; 133: 454-64.416. Mroczko B, Lukaszewicz-Zajac M, Wereszczynska-Siemiatkowska U, Groblewska M, Gryko M,Kedra B, Jurkowska G, Szmitkowski M. Clinical significance <strong>of</strong> the measurements <strong>of</strong> serum matrixmetalloproteinase-9 and its inhibitor (tissue inhibitor <strong>of</strong> metalloproteinase-1) in patients with pancreaticcancer: metalloproteinase-9 as an independent prognostic factor. Pancreas 2009; 38: 613-8.417. Faccioli N, Crippa S, Bassi C, D'On<strong>of</strong>rio M. Contrast-enhanced ultrasonography <strong>of</strong> the pancreas.Pancreatology 2009; 9: 560-6.418. Badea R, Seicean A, Diaconu B, Stan-Iuga R, Sparchez Z, Tantau M, Socaciu M. Contrastenhancedultrasound <strong>of</strong> the pancreas – a method beyond its potential or a new diagnostic standard? JGastrointestin Liver Dis 2009; 18: 237-42.419. Iglesias García J, Lariño Noia J, Domínguez Muñoz JE. Endoscopic ultrasound in the diagnosisand staging <strong>of</strong> pancreatic cancer. Rev Esp Enferm Dig 2009; 101: 631-8.420. Sreenarasimhaiah J. Interventional endoscopic ultrasound: the next frontier in gastrointestinalendoscopy. Am J Med Sci 2009: 338: 319-24.